Moderna, Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRNA.MX | 6547.TWO | 0MGB.IL | 261780.KQ | 068270.KS | 0A3M.IL | |
|---|---|---|---|---|---|---|
| Market cap | 1.91T | 15.63B | 295.98B | 103.62B | 49.02T | 25.17B |
| P/E (TTM) | — | — | 52.2 | — | — | 5.1 |
| Forward P/E | — | 32.6 | — | — | — | 5.1 |
| Price/book | 15.1 | 4.4 | 8.4 | — | — | 1.1 |
| Dividend yield | — | — | — | — | 0.36% | — |
| 1-year change | +968.65% | +42.31% | +93.74% | +44.97% | +20.07% | −13.17% |
| Today | +13.74% | −2.16% | +2.03% | −2.90% | +7.50% | +2.81% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All MRNA.MX news ›Moderna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its Success
Moderna and Merck have developed a cancer vaccine that has been highly effective in treating melanoma patients. In a late-stage trial, it reduced the risk of death and melanoma recurrence by 42% when paired with Keytruda. The problem is…
Could Investing in Moderna's Stock Double Your Money?
The healthcare stock has generated massive returns this year and may still have room to rise even higher in the future. Moderna (MRNA +3.45%) has generated terrific gains for investors this year, as the stock has skyrocketed more than 650%…
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Moderna surges on pre-earnings momentum, Pfizer dips after beating estimates and raising guidance, and Merck drops despite launching a new trial. When stock prices and headlines point in opposite directions across the sector, something…
CK Life Sciences’ Sequencio Therapeutics to Present New Data from Lead Cancer Vaccine Programmes at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting
By Badylon Kawanda Bakiman KINSHASA, DR CONGO – The Democratic Republic of… By Ajong Mbapndah L Ghanaian President John Dramani Mahama has welcomed what… By Deng Heskey Machol JUBA, South Sudan – South Sudan has taken… By Ajong Mbapndah L…
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
BioSpace Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (NASDAQ: PSNL) announced today
A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
Danish biotech Genmab has seen its shares double in three months after a string of major cancer drug trial successes, giving fresh momentum to its push to take greater control of the medicines it develops and sells. Shares in the roughly…
Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial
WJAR Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial
After mRNA Trial Setbacks, BioNTech Still Pushing Ahead in Cancer
Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies GenomeWeb Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies
Lytix's ruxotemitide clears Phase II melanoma pCR bar, advancing to Phase III
AllSci Norway-based Lytix Biopharma (Euronext Growth Oslo: LYTIX) announced that the Phase II NeoLIPA study of intratumoral oncolytic peptide ruxotemitide (LTX-315) combined with pembrolizumab met its prespecified criterio
Moderna, Inc. $MRNA Stock Sold by Bank Julius Baer & Co. Ltd Zurich
MRNA stock opened at $220.83 on Tuesday. The stock has a 50-day moving average price of $184.00 and a two-hundred day moving average price of $87.42. The company has a current ratio of 2.29, a quick ratio of 2.18 and a debt-to-equity ratio…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com35
- seekingalpha.com24
- 247wallst.com23
- theglobeandmail.com22
- fool.com18
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.